Categories
Connect with us on LinkedIn
5 Key Takeaways from the FDA’s Real-World Evidence Guidance
A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance...
How MMI Leveraged Castor to Fulfill MDR Requirements for Their Groundbreaking Microsurgery Robot
Castor provided MMI with a compliant, user-friendly platform that was able to enhance enrollment by over 500% and...
Navigating the Evolving Regulatory and Data Landscape
A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance...
DTx company leverages Castor’s Real-World Evidence platform in Registry study
How Castor’s eClinical system helped a DTx company to collect Real World Evidence for their behavioral disorder treatment
Castor Product Spotlight: What’s new in 2024?
In this on-demand webinar, we delve into the latest product updates on eCOA, data entry, reports, and dashboards....
Do We Still Need Patients in Tomorrow’s Trials? Modeling Placebo Effect and Beyond
Discover the transformative role of AI in clinical trials, with expert insights from Derk Arts and MaryAnne Rizk...
eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy
The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data...
Castor Introduces Castor CoPilot, A Novel AI Solution for Clinical Trials
The partnership will streamline the synchronization of clinical trial and real-world data throughout the clinical research stages.
Achieving Post-Market Success: Harnessing RWE for Accelerated Market Acceptance
Watch our on-demand webinar featuring CVS Healthspire™ Life Sciences Solutions
Evaluating “Bother” as a Component of Patient-Reported Outcomes in Clinical Studies
Patient-reported outcome (PRO) instruments refer to multiple scales and questionnaires designed to collect patients’ personal feedback on their...
New Industry Standard Research Report Sheds Light on eCOA/ePRO Market Dynamics
The latest report from Industry Standard Research (ISR) Sheds Light on eCOA/ePRO Market Dynamics. The Performance of Castor...
Under pressure: what it takes to validate a cuffless blood pressure device
When a company brings a cuffless, continuous blood pressure monitor to market, the wristband is the easy part....
The impact of an AI-enabled consent process
Exploring how early engagement with trial participants through an AI enabled chatbot can enhance both comprehension and satisfaction.
Under Pressure: How Aktiia Brought Their Continuous BP Device to Global Markets with high quality data
Watch this on-demand LinkedIn Live webinar with Castor CEO & founder, Derk Arts, featuring fellow data-driven pioneer, Jay...
5 Best Practices for Getting Started with ePRO
Electronic Patient Reported Outcomes (ePRO) can become a powerhouse for gathering high-quality data directly from patients. To help...
Can BYOD help us end an era of waste and burden in eCOA?
Bring Your Own Device (BYOD) represents the future of eCOA, and prioritizes flexibility & convenience for trial participants....
Spring updates & a highlight on ePRO in Oncology
Listen in as Derk gives an update on what is happening at Castor this March, as well as...
Measuring the true patient experience in Cancer Trials with eCOA / ePRO
Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer...
Connect with us on LinkedIn
